Literature DB >> 15098002

Dopamine in drug abuse and addiction: results from imaging studies and treatment implications.

N D Volkow1, J S Fowler, G-J Wang, J M Swanson.   

Abstract

The involvement of dopamine in drug reinforcement is well recognized but its role in drug addiction is much less clear. Imaging studies have shown that the reinforcing effects of drugs of abuse in humans are contingent upon large and fast increases in dopamine that mimic but exceed in the intensity and duration those induced by dopamine cell firing to environmental events. In addition, imaging studies have also documented a role of dopamine in motivation, which appears to be encoded both by fast as well as smooth DA increases. Since dopamine cells fire in response to salient stimuli, the supraphysiological activation by drugs is likely to be experienced as highly salient (driving attention, arousal conditioned learning and motivation) and may also reset the thresholds required for environmental events to activate dopamine cells. Indeed, imaging studies have shown that in drug-addicted subjects, dopamine function is markedly disrupted (decreases in dopamine release and in dopamine D2 receptors in striatum) and this is associated with reduced activity of the orbitofrontal cortex (neuroanatomical region involved with salience attribution and motivation and implicated in compulsive behaviors) and the cingulate gyrus (neuroanatomical region involved with inhibitory control and attention and implicated in impulsivity). However, when addicted subjects are exposed to drug-related stimuli, these hypoactive regions become hyperactive in proportion to the expressed desire for the drug. We postulate that decreased dopamine function in addicted subjects results in decreased sensitivity to nondrug-related stimuli (including natural reinforcers) and disrupts frontal inhibition, both of which contribute to compulsive drug intake and impaired inhibitory control. These findings suggest new strategies for pharmacological and behavioral treatments, which focus on enhancing DA function and restoring brain circuits disrupted by chronic drug use to help motivate the addicted subject in activities that provide alternative sources of reinforcement, counteract conditioned responses, enhance their ability to control their drive to take drugs and interfere with their compulsive administration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15098002     DOI: 10.1038/sj.mp.4001507

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  284 in total

1.  Stress and alcohol cues exert conjoint effects on go and stop signal responding in male problem drinkers.

Authors:  Martin Zack; Tracy M Woodford; Anne M Tremblay; Lindsay Steinberg; Laurie A Zawertailo; Usoa E Busto
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

2.  Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.

Authors:  Amir H Rezvani; Susan Slade; Cori Wells; Ann Petro; Lawrence Lumeng; Ting-Kai Li; Yingxian Xiao; Milton L Brown; Mikell A Paige; Brian E McDowell; Jed E Rose; Kenneth J Kellar; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2010-06-10       Impact factor: 4.530

3.  Adolescent social defeat increases adult amphetamine conditioned place preference and alters D2 dopamine receptor expression.

Authors:  A R Burke; M J Watt; G L Forster
Journal:  Neuroscience       Date:  2011-09-10       Impact factor: 3.590

4.  Dopaminergic modulation of risky decision-making.

Authors:  Nicholas W Simon; Karienn S Montgomery; Blanca S Beas; Marci R Mitchell; Candi L LaSarge; Ian A Mendez; Cristina Bañuelos; Colin M Vokes; Aaron B Taylor; Rebecca P Haberman; Jennifer L Bizon; Barry Setlow
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

5.  Amping up effort: effects of d-amphetamine on human effort-based decision-making.

Authors:  Margaret C Wardle; Michael T Treadway; Leah M Mayo; David H Zald; Harriet de Wit
Journal:  J Neurosci       Date:  2011-11-16       Impact factor: 6.167

6.  Episodic withdrawal promotes psychomotor sensitization to morphine.

Authors:  Patrick E Rothwell; Jonathan C Gewirtz; Mark J Thomas
Journal:  Neuropsychopharmacology       Date:  2010-09-01       Impact factor: 7.853

7.  Cracking the moody brain: the rewards of self starvation.

Authors:  Caroline F Zink; Daniel R Weinberger
Journal:  Nat Med       Date:  2010-12       Impact factor: 53.440

8.  Probabilistic reward- and punishment-based learning in opioid addiction: Experimental and computational data.

Authors:  Catherine E Myers; Jony Sheynin; Tarryn Balsdon; Andre Luzardo; Kevin D Beck; Lee Hogarth; Paul Haber; Ahmed A Moustafa
Journal:  Behav Brain Res       Date:  2015-09-14       Impact factor: 3.332

Review 9.  Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse.

Authors:  F Ivy Carroll; James L Howard; Leonard L Howell; Barbara S Fox; Michael J Kuhar
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

10.  Cardiovascular and Subjective Effects of the Novel Adenosine A(2A) Receptor Antagonist SYN115 in Cocaine Dependent Individuals.

Authors:  Sd Lane; Ce Green; Jl Steinberg; L Ma; Jm Schmitz; N Rathnayaka; Sd Bandak; S Ferre; Fg Moeller
Journal:  J Addict Res Ther       Date:  2012-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.